Literature DB >> 11227669

Laparoscopic cholecystofistulectomy for preoperatively diagnosed cholecystoduodenal fistula.

F Chikamori1, K Okumiya, A Inoue, N Kuniyoshi.   

Abstract

The presence of cholecystoduodenal fistula, a rare condition, has been one of the reasons for conversion from laparoscopic cholecystectomy to open cholecystectomy. Here we report a patient with cholecystocholedocholithiasis complicated by cholecystoduodenal fistula, diagnosed preoperatively and treated by combined endoscopic sphincterotomy and laparoscopic cholecystofistulectomy. After the removal of multiple bile-duct stones by endoscopic sphincterotomy, the patient underwent laparoscopic cholecystofistulectomy. We were able to resect the fistula without cleavage, using an endoscopic linear stapling device, because we had been able to confirm the site of the fistula preoperatively. The patient's postoperative course was uneventful. We conclude that laparoscopic cholecystofistulectomy by skilled laparoscopic surgeons can be adopted as a first-choice treatment for cholecystoduodenal fistula.

Entities:  

Mesh:

Year:  2001        PMID: 11227669     DOI: 10.1007/s005350170141

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  3 in total

1.  Laparoscopic repair of various types of biliary-enteric fistula: three cases.

Authors:  J H Lee; H S Han; S K Min; H K Lee
Journal:  Surg Endosc       Date:  2004-02       Impact factor: 4.584

2.  Acute acalculous cholecystitis associated with cholecystoduodenal fistula and duodenal bleeding. A case report.

Authors:  Sang Bae Lee; Kwang Hyun Ryu; Ji Kon Ryu; Hoi Jin Kim; Jin Kwang Lee; Hyun Seung Jeong; Jin Soo Bae
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

3.  Choledochoduodenal fistula in Mainland China: a review of epidemiology, etiology, diagnosis and management.

Authors:  Ming-Bing Wu; Wen-Feng Zhang; Ying-Lin Zhang; Di Mu; Jian-Ping Gong
Journal:  Ann Surg Treat Res       Date:  2015-10-28       Impact factor: 1.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.